![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Norbrook Laboratories Limited Newry Ie, based in United Kingdom, is a pharmaceutical company.
One of their significant offerings is Oxytetracycline dihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1997-127 - Rev 06
This Chemical Type CEP, issued on April 19, 2017, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 199 associated with this CEP further emphasizes